'Hypertension' and 'microalbuminuria': The bell tolls for thee

被引:57
作者
Forman, JP
Brenner, BM
机构
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA
关键词
hypertension; microalbminuria; cardiovascular; blood pressure; albuminuria; origins of disease;
D O I
10.1038/sj.ki.5000056
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Since the terms 'hypertension' and 'microalbuminuria' were first defined, data from numerous studies have documented the continuous, rather than dichotomous, relation between blood pressure, albumin excretion, and cardiovascular disease. Lower blood pressures, down to at least 115/75 mmHg, and lower albumin excretions, below an estimated 2 mg/day, are associated with less cardiovascular risk. We hypothesize that the abundances of modern civilization superimposed on the Paleolithic genotype of humans, which has not substantially changed in the last 10 000 years, have considerably shifted the 'normal' values for blood pressure and various biochemical indices such as albuminuria still found in today's stone-aged cultures to the 'neo-normal' values observed today in the rest of the modern world. Defining a large portion of the population as 'normal' based upon these dichotomous 'neo-normal' standards is not supported by the data, and therefore seems unjustifiable. We propose that the medical community consider abandoning the terms 'hypertension' and 'microalbuminuria' in favor of 'blood pressure-associated' and 'albuminuria-associated' disease.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 69 条
[1]  
ANDERSON TW, 1978, LANCET, V2, P1139
[2]  
[Anonymous], 1991, JAMA, V265, P3255
[3]  
[Anonymous], 1988, ARCH INTERN MED, V148, P1023
[4]  
[Anonymous], 1984, ARCH INTERN MED, V144, P1045
[5]  
[Anonymous], 1982, Lancet, V1, P185
[6]  
[Anonymous], 1977, JAMA-J AM MED ASSOC, V237, P255, DOI DOI 10.1001/JAMA.1977.03270300059008
[7]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[8]   Impact of achieved blood pressure on cardiovascular outcomes in the irbesartan diabetic nephropathy trial [J].
Berl, T ;
Hunsicker, LG ;
Lewis, JB ;
Pfeffer, MA ;
Porush, JG ;
Rouleau, JL ;
Drury, PL ;
Esmatjes, E ;
Hricik, D ;
Pohl, M ;
Raz, I ;
Vanhille, P ;
Wiegmann, TB ;
Wolfe, BM ;
Locatelli, F ;
Goldhaber, SZ ;
Lewis, EJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2170-2179
[9]  
Black HR, 1997, ARCH INTERN MED, V157, P2413
[10]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504